AMGN
Price
$267.70
Change
-$1.71 (-0.63%)
Updated
Sep 22, 6:59 PM EST
38 days until earnings call
BIIB
Price
$257.68
Change
-$1.25 (-0.48%)
Updated
Sep 22, 6:59 PM EST
31 days until earnings call

Analysis and predictions AMGN vs BIIB

Header iconAMGN vs BIIB Comparison
Open Charts AMGN vs BIIBBanner chart's image
Amgen
Price$267.70
Change-$1.71 (-0.63%)
Volume$967.52K
CapitalizationN/A
Biogen
Price$257.68
Change-$1.25 (-0.48%)
Volume$449.19K
CapitalizationN/A
View a ticker or compare two or three
AMGN vs BIIB Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AMGN vs. BIIB commentary
Sep 23, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Hold and BIIB is a StrongSell.

COMPARISON
Comparison
Sep 23, 2023
Stock price -- (AMGN: $267.70 vs. BIIB: $257.68)
Brand notoriety: AMGN and BIIB are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 75% vs. BIIB: 81%
Market capitalization -- AMGN: $144.11B vs. BIIB: $37.5B
AMGN [@Pharmaceuticals: Major] is valued at $144.11B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $37.5B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $522.24B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $80.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 4 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).

  • AMGN’s FA Score: 4 green, 1 red.
  • BIIB’s FA Score: 0 green, 5 red.
According to our system of comparison, AMGN is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 4 TA indicator(s) are bullish.

  • AMGN’s TA Score: 4 bullish, 5 bearish.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +2.68% price change this week, while BIIB (@Pharmaceuticals: Major) price change was +1.13% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.88%. For the same industry, the average monthly price growth was -3.23%, and the average quarterly price growth was -0.33%.

Reported Earning Dates

AMGN is expected to report earnings on Oct 31, 2023.

BIIB is expected to report earnings on Oct 24, 2023.

Industries' Descriptions

@Pharmaceuticals: Major (-1.88% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for AMGN with price predictions.
OPEN
A.I.dvisor published
a Summary for BIIB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AMGN($144B) has a higher market cap than BIIB($37.5B). AMGN has higher P/E ratio than BIIB: AMGN (18.15) vs BIIB (14.12). AMGN YTD gains are higher at: 4.637 vs. BIIB (-6.948). AMGN has higher annual earnings (EBITDA): 14.8B vs. BIIB (3.82B). AMGN has more cash in the bank: 34.2B vs. BIIB (6.08B). BIIB has less debt than AMGN: BIIB (6.59B) vs AMGN (61.5B). AMGN has higher revenues than BIIB: AMGN (26.6B) vs BIIB (9.97B).
AMGNBIIBAMGN / BIIB
Capitalization144B37.5B384%
EBITDA14.8B3.82B388%
Gain YTD4.637-6.948-67%
P/E Ratio18.1514.12128%
Revenue26.6B9.97B267%
Total Cash34.2B6.08B563%
Total Debt61.5B6.59B933%
FUNDAMENTALS RATINGS
AMGN vs BIIB: Fundamental Ratings
AMGN
BIIB
OUTLOOK RATING
1..100
554
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
14100
SMR RATING
1..100
1146
PRICE GROWTH RATING
1..100
1154
P/E GROWTH RATING
1..100
6257
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (12) in the Biotechnology industry is significantly better than the same rating for BIIB (89). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

AMGN's Profit vs Risk Rating (14) in the Biotechnology industry is significantly better than the same rating for BIIB (100). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

AMGN's SMR Rating (11) in the Biotechnology industry is somewhat better than the same rating for BIIB (46). This means that AMGN’s stock grew somewhat faster than BIIB’s over the last 12 months.

AMGN's Price Growth Rating (11) in the Biotechnology industry is somewhat better than the same rating for BIIB (54). This means that AMGN’s stock grew somewhat faster than BIIB’s over the last 12 months.

BIIB's P/E Growth Rating (57) in the Biotechnology industry is in the same range as AMGN (62). This means that BIIB’s stock grew similarly to AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGN
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bullish Trend 1 day ago
53%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
49%
Advances
ODDS (%)
Bullish Trend 4 days ago
53%
Declines
ODDS (%)
Bearish Trend 1 day ago
54%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Aroon
ODDS (%)
Bearish Trend 1 day ago
46%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GBPIX10.56N/A
N/A
Meeder Global Allocation Institutional
KLCKX19.32N/A
N/A
Federated Hermes Kaufmann Large Cap R
SBLYX57.58-0.01
-0.02%
ClearBridge Large Cap Growth I
NFALX22.78-0.02
-0.09%
Neuberger Berman Focus I
LCMGX14.73-0.11
-0.74%
Lord Abbett Micro Cap Growth C

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with GILD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then GILD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-0.63%
GILD - AMGN
53%
Loosely correlated
-0.35%
JNJ - AMGN
48%
Loosely correlated
-0.72%
BMY - AMGN
46%
Loosely correlated
-0.30%
ABBV - AMGN
43%
Loosely correlated
-0.45%
MRK - AMGN
39%
Loosely correlated
-0.37%
More

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AZN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
-0.48%
AZN - BIIB
34%
Loosely correlated
+1.21%
JNJ - BIIB
32%
Poorly correlated
-0.72%
MRK - BIIB
29%
Poorly correlated
-0.37%
PFE - BIIB
29%
Poorly correlated
-0.49%
ABBV - BIIB
27%
Poorly correlated
-0.45%
More